Pharmaceutical
Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01
Advanced pharmaceutical formulation for targeted therapeutic intervention.